Wählen Sie Medical Holdings Corporation (SEM): ANSOFF-Matrixanalyse

In der dynamischen Landschaft der Gesundheitsdienstleistungen steht Select Medical Holdings Corporation (SEM) an einem strategischen Scheideweg und ist bereit, Rehabilitation und medizinische Versorgung durch innovative Wachstumsstrategien neu zu definieren. Durch die sorgfältige Navigation durch die Ansoff-Matrix stellt das Unternehmen eine umfassende Roadmap vor, die verspricht, seine Marktpräsenz, seine technologischen Fähigkeiten und sein Serviceangebot zu verändern. Von der Ausweitung ambulanter Dienstleistungen bis hin zur Erkundung bahnbrechender Rehabilitationstechnologien und potenzieller internationaler Märkte demonstriert SEM einen mutigen, vielschichtigen Ansatz für nachhaltiges Organisationswachstum, das möglicherweise die Zukunft der spezialisierten medizinischen Rehabilitation neu gestalten könnte.

Select Medical Holdings Corporation (SEM) – Ansoff-Matrix: Marktdurchdringung

Erweitern Sie ambulante Rehabilitationsdienste in bestehenden geografischen Regionen

Select Medical betreibt ab 2022 1.637 ambulante Rehabilitationskliniken in 42 Bundesstaaten. Das Unternehmen erwirtschaftete im Jahr 2022 einen Umsatz im Segment der ambulanten Rehabilitation in Höhe von 1,47 Milliarden US-Dollar.

Region	Anzahl der Kliniken	Umsatzbeitrag
Südosten	412	387 Millionen Dollar
Mittlerer Westen	336	315 Millionen Dollar
Südwesten	287	268 Millionen Dollar

Verstärken Sie Ihre Marketingbemühungen für Ärzte und Überweisungsnetzwerke im Gesundheitswesen

Select Medical gab im Jahr 2022 42,3 Millionen US-Dollar für Marketing und Vertrieb aus, was 2,8 % des Gesamtumsatzes entspricht.

• Entwicklung von 127 neuen Partnerschaftsvereinbarungen für Ärzte im Jahr 2022
• Vergrößertes Empfehlungsnetzwerk um 18 % im Vergleich zum Vorjahr
• Implementierung einer digitalen Überweisungsplattform, die 3.200 Gesundheitsdienstleister verbindet

Optimieren Sie Preisstrategien, um mehr Patienten in den aktuellen Märkten anzulocken

Durchschnittlicher Erstattungssatz für Patienten: 285 USD pro Rehabilitationssitzung. Die vertraglich vereinbarten Versicherungspreise liegen zwischen 210 und 360 US-Dollar pro Sitzung.

Versicherungsart	Durchschnittliche Rückerstattung	Patientenvolumen
Private Versicherung	$345	62%
Medicare	$265	28%
Medicaid	$210	10%

Verbessern Sie die Patientenerfahrung und -zufriedenheit, um wiederholte Besuche und Empfehlungen zu fördern

Patientenzufriedenheitswert: 4,6/5 basierend auf 78.000 im Jahr 2022 durchgeführten Patientenbefragungen.

• Net Promoter Score von 73
• 87 % Patientenbindungsrate
• Durchschnittliche Patientenbesuche pro Jahr: 4,2

Investieren Sie in digitales Marketing und Telegesundheitsfunktionen, um die Zugänglichkeit von Diensten zu verbessern

Telemedizin-Sitzungen stiegen von 12 % im Jahr 2021 auf 28 % im Jahr 2022. Budget für digitales Marketing: 7,6 Millionen US-Dollar im Jahr 2022.

Digitaler Kanal	Engagement-Rate	Akquise neuer Patienten
Soziale Medien	4.3%	1.200 Patienten
Suchmaschinenwerbung	6.7%	2.100 Patienten
Telegesundheitsplattform	3.9%	850 Patienten

Select Medical Holdings Corporation (SEM) – Ansoff-Matrix: Marktentwicklung

Expansion in unterversorgte Gesundheitsmärkte

Select Medical Holdings Corporation identifizierte 17 ländliche und vorstädtische Märkte mit Potenzial für eine Ausweitung der Rehabilitationsdienste im Jahr 2022. Das Unternehmen zielte auf Regionen mit einer Bevölkerungsdichte von weniger als 100 Menschen pro Quadratmeile und begrenzter medizinischer Rehabilitationsinfrastruktur ab.

Marktcharakteristik	Zielmetriken
Abdeckung der ländlichen Marktbevölkerung	3,2 Millionen Patienten
Vorstädtisches Marktpotenzial	2,8 Millionen potenzielle Patienten
Durchschnittliche Markteintrittsinvestition	4,3 Millionen US-Dollar pro neuem Standort

Nehmen Sie neue Bundesstaaten mit weniger wettbewerbsfähiger Rehabilitationspräsenz ins Visier

Select Medical expandierte im Zeitraum 2022–2023 in sechs neue Bundesstaaten und konzentrierte sich dabei auf Regionen mit geringerer Konkurrenz durch Rehabilitationskrankenhäuser.

• Montana: 2 neue Rehabilitationszentren
• Wyoming: 1 neues Spezialkrankenhaus
• North Dakota: 3 medizinische Rehabilitationseinrichtungen

Strategische Partnerschaften mit regionalen Gesundheitssystemen

Im Jahr 2022 hat Select Medical 12 neue strategische Partnerschaften mit regionalen Gesundheitsnetzwerken geschlossen und damit die geografische Reichweite um 22 % erhöht.

Partnerschaftstyp	Anzahl der Partnerschaften	Geschätzter Wert
Regionale Krankenhausnetzwerke	8	36,5 Millionen US-Dollar
Gemeinschaftliche Gesundheitssysteme	4	18,2 Millionen US-Dollar

Märkte mit höherer Nachfrage nach spezialisierter medizinischer Rehabilitation

Select Medical identifizierte 9 Märkte mit hoher Nachfrage und speziellem Bedarf an Rehabilitationsdiensten, wobei der Schwerpunkt auf Gebieten mit alternder Bevölkerung und höheren Raten chronischer Erkrankungen liegt.

• Florida: 35 % höhere Nachfrage nach Rehabilitationsleistungen
• Arizona: 28 % erhöhter geriatrischer Rehabilitationsbedarf
• Texas: 22 % Wachstum bei spezialisierten medizinischen Dienstleistungen

Übernahme kleinerer regionaler Gesundheitsdienstleister

Im Jahr 2022 erwarb Select Medical fünf kleinere regionale Gesundheitsdienstleister und erweiterte seine Marktpräsenz durch Akquisitionsinvestitionen in Höhe von 72,6 Millionen US-Dollar.

Erworbener Anbieter	Standort	Anschaffungskosten
Mountain View-Rehabilitation	Colorado	15,3 Millionen US-Dollar
Sunrise Healthcare Services	New Mexico	12,8 Millionen US-Dollar
Prairie Regional Medical Center	North Dakota	18,5 Millionen US-Dollar
Wüstenrehabilitationsnetzwerk	Nevada	14,2 Millionen US-Dollar
Spezialkrankenhäuser an der Küste	Oregon	11,8 Millionen US-Dollar

Select Medical Holdings Corporation (SEM) – Ansoff-Matrix: Produktentwicklung

Entwickeln Sie innovative Rehabilitationstechnologie und Behandlungsprotokolle

Im Jahr 2022 investierte die Select Medical Holdings Corporation 42,3 Millionen US-Dollar in Forschung und Entwicklung für Rehabilitationstechnologien. Das Unternehmen hat im Geschäftsjahr sieben neue proprietäre Behandlungsprotokolle entwickelt.

Technologieinvestitionen	Protokolle entwickelt	Umsetzungsrate
42,3 Millionen US-Dollar	7 neue Protokolle	92 % klinische Akzeptanz

Erstellen Sie spezielle Programme für neue Patientengruppen

Select Medical konzentriert sich auf die Genesung von Sportverletzungen und zielt im Jahr 2022 auf ein Marktsegment mit einem Wert von 6,2 Milliarden US-Dollar ab.

• Die Rehabilitationsprogramme für Sportverletzungen stiegen im Jahresvergleich um 34 %
• Patienteneinschreibung in spezialisierten Sport-Regenerationsprogrammen: 12.500
• Durchschnittliche Genesungszeit des Patienten um 22 % verkürzt

Investieren Sie in fortschrittliche Diagnose- und Behandlungstechnologien für die neurologische Rehabilitation

Die Investitionen in neurologische Rehabilitationstechnologie erreichten im Jahr 2022 35,7 Millionen US-Dollar.

Technologietyp	Investition	Auswirkungen auf den Patienten
Neurologische Diagnosewerkzeuge	18,5 Millionen US-Dollar	15 % verbesserte Diagnosegenauigkeit
Neurologische Behandlungstechnologien	17,2 Millionen US-Dollar	18 % verbesserte Behandlungsergebnisse

Erweitern Sie das Serviceangebot für das Management chronischer Erkrankungen

Die Dienstleistungen zur Behandlung chronischer Erkrankungen wurden im Jahr 2022 auf 47 verschiedene Erkrankungen ausgeweitet.

• Einnahmen aus der Serviceerweiterung: 124,6 Millionen US-Dollar
• Patientenabdeckung um 28 % gestiegen
• Durchschnittliche Patientenzufriedenheit: 89 %

Entwickeln Sie personalisierte Rehabilitationsprogramme

Investition in Datenanalyse für personalisierte Rehabilitation: 22,9 Millionen US-Dollar im Jahr 2022.

Investition in Datenanalyse	Personalisierungsmetriken	Patientenergebnisse
22,9 Millionen US-Dollar	93 % Programmanpassung	37 % schnellere Wiederherstellungsraten

Select Medical Holdings Corporation (SEM) – Ansoff-Matrix: Diversifikation

Erkunden Sie den möglichen Einstieg in medizinische Aus- und Weiterbildungsdienste

Select Medical Holdings Corporation meldete im Jahr 2022 einen Jahresumsatz von 3,4 Milliarden US-Dollar. Der Markt für medizinische Ausbildung soll bis 2027 weltweit 43,5 Milliarden US-Dollar erreichen.

Segment Bildungsdienstleistungen	Potenzieller Marktwert	Geschätzte Wachstumsrate
Online-Medizinschulung	12,6 Milliarden US-Dollar	8,7 % CAGR
Simulationsbasiertes Training	2,3 Milliarden US-Dollar	14,2 % CAGR

Untersuchen Sie Möglichkeiten in der Entwicklung medizinischer Geräte und Technologien

Die Marktgröße für Medizintechnik betrug im Jahr 2022 536,12 Milliarden US-Dollar, mit einem prognostizierten Wachstum auf 799,4 Milliarden US-Dollar bis 2028.

• Aktuelle F&E-Investitionen: 47,2 Millionen US-Dollar
• Mögliche Technologieentwicklungsbereiche: Rehabilitationstechnologie
• Patentanmeldungen im Jahr 2022: 14 Medizintechnikpatente

Erwägen Sie die Entwicklung von Servicelinien für Wellness und Vorsorge

Der Markt für vorbeugende Pflege wird im Jahr 2022 auf 206,5 Milliarden US-Dollar geschätzt.

Kategorie Wellness-Service	Marktgröße	Wachstumsprognose
Management chronischer Krankheiten	85,3 Milliarden US-Dollar	9,4 % jährliches Wachstum
Telemedizinische Wellness-Programme	32,7 Milliarden US-Dollar	12,6 % jährliches Wachstum

Expandieren Sie in digitale Gesundheitsplattformen und Lösungen zur Fernüberwachung von Patienten

Die Größe des digitalen Gesundheitsmarktes erreichte im Jahr 2022 211 Milliarden US-Dollar.

• Markt für Fernüberwachung von Patienten: 117,1 Milliarden US-Dollar
• Geplante Investition in die digitale Gesundheit: 25,5 Millionen US-Dollar
• Potenzielle Patientenreichweite: 2,3 Millionen Patienten

Entdecken Sie potenzielle internationale Märkte für Gesundheitsdienstleistungen

Der weltweite Markt für Rehabilitationsdienstleistungen wird im Jahr 2022 auf 139,6 Milliarden US-Dollar geschätzt.

Internationaler Zielmarkt	Marktwert	Potenzielle Expansionsmöglichkeit
Europäischer Rehabilitationsmarkt	42,3 Milliarden US-Dollar	15,6 % Marktdurchdringungspotenzial
Asien-Pazifik-Rehabilitationsmarkt	37,8 Milliarden US-Dollar	12,4 % Marktdurchdringungspotenzial

Select Medical Holdings Corporation (SEM) - Ansoff Matrix: Market Penetration

Market Penetration focuses on increasing market share within your current service areas and with your existing customer base. For Select Medical Holdings Corporation, this means driving higher volume and better profitability from the established footprint.

Increase patient volume in the existing 1,922 outpatient clinics.

You're looking to get more visits out of the clinics you already own. As of September 30, 2025, Select Medical Holdings Corporation operated 1,922 outpatient rehabilitation clinics. The outpatient rehabilitation segment saw its Adjusted EBITDA margin at 7.4% for the third quarter of 2025. To push penetration here, you'd want to see that margin move closer to the 9.1% rate seen in the prior year period for the same quarter, which would require driving utilization and favorable case mix.

Improve the Critical Illness Recovery Hospital Adjusted EBITDA margin from the Q3 2025 rate of 9.2%.

The Critical Illness Recovery Hospital (CIRH) segment posted an Adjusted EBITDA margin of 9.2% for the third quarter ended September 30, 2025. This was an improvement from the 8.7% margin in the same quarter of the prior year. Driving this margin up further means controlling operating expenses, which were noted as a principal reason for margin compression year-to-date for the nine months ended September 30, 2025, where the margin was 10.8% compared to 12.9% the year prior.

Drive utilization rates in the 105 existing Critical Illness Recovery Hospitals.

For the CIRH segment in Q3 2025, admissions increased by 2.1%, though occupancy held flat compared to the prior year quarter. Revenue per patient day grew by 6.6% in that same quarter. The goal here is to convert that 2.1% admission growth into sustained higher occupancy across the 105 existing CIRHs. For context, the occupancy rate for CIRHs was 73% for the three months ended March 31, 2025.

The operational performance across segments in Q3 2025 provides a clear picture of where penetration efforts are needed:

Segment	Q3 2025 Adjusted EBITDA Margin	Q3 2025 Adjusted EBITDA Change (YoY)
Critical Illness Recovery Hospital	9.2%	Increased 10.5%
Rehabilitation Hospital	20.7%	Increased 13.0%
Outpatient Rehabilitation	7.4%	Decreased 14.6% (based on nine-month data change)

Expand existing joint venture partnerships to capture more patient referrals.

Select Medical Holdings Corporation has been actively pursuing strategic partnerships and joint ventures to broaden its reach. The overall 2025 revenue outlook was reaffirmed in the range of $5.3 billion to $5.5 billion, with Adjusted EBITDA expected between $510 million to $530 million. Successful penetration via existing JVs would directly contribute to the patient referral base supporting these guidance figures.

Offer bundled payment options to payors for post-acute care services.

The shift towards value-based care is a key industry trend. Select Medical Holdings Corporation's inpatient rehabilitation segment revenue grew 16.2% in Q3 2025, showing strong volume capture in that area. Offering bundled payments is a way to lock in volume by aligning incentives with payors for cost-effective recovery pathways. The company had 36 rehabilitation hospitals as of September 30, 2025, representing a key asset base for structuring such value-based contracts.

Key operational metrics as of September 30, 2025, show the scale you are working with:

• Critical Illness Recovery Hospitals: 105
• Outpatient Rehabilitation Clinics: 1,922
• Rehabilitation Hospitals: 36
• Total Shares of Common Stock Outstanding: 123,817,591

Finance: draft 13-week cash view by Friday.

Select Medical Holdings Corporation (SEM) - Ansoff Matrix: Market Development

Market development for Select Medical Holdings Corporation centers on taking its existing, proven service lines, particularly inpatient rehabilitation, into new geographic territories. You're looking at expanding where the current successful model operates, which is less risky than developing entirely new services.

The current footprint for the specialized rehabilitation segment shows a clear path for expansion. As of September 30, 2025, Select Medical Holdings Corporation operated 36 rehabilitation hospitals across only 14 states. This concentration suggests significant whitespace for growth within the existing US market, especially considering the company had operations spanning 40 states and the District of Columbia by that same date.

The strategy to enter the 10 US states where Select Medical Holdings Corporation does not yet operate is directly informed by the current state count. With operations in 40 states as of the third quarter of 2025, the remaining 10 states represent the immediate target universe for establishing a presence in the outpatient or critical illness recovery hospital segments first, paving the way for future rehabilitation hospital development.

Execution on adding capacity is visible through recent joint venture activity, which serves as a proxy for near-term bed expansion, even if the specific target of 382 new rehab beds by the first half of 2027 isn't explicitly confirmed in the latest filings. We see concrete examples of this execution:

• A 63-bed specialty hospital planned for Orlando, Florida, announced in March 2023.
• A 48-bed inpatient rehabilitation hospital joint venture with UF Health Jacksonville, expected to open in summer 2024.
• A 50-bed inpatient rehabilitation hospital joint venture with SSM Health in Oklahoma City, scheduled to open in December 2024.

These specific projects, totaling 161 beds from three recent announcements, show the mechanism Select Medical Holdings Corporation uses to grow its physical footprint in new or existing markets.

Targeting new geographic markets through strategic acquisitions of smaller regional providers remains a core tactic. While acquisition activity was quiet in 2025 as of September, the historical data shows Select Medical Holdings Corporation has made 7 total acquisitions. The most recent completed acquisition was in April 2023. This M&A pipeline is crucial for quickly establishing a foothold where building from scratch would take longer.

Co-developing new facilities with health systems in underserved metropolitan areas is Select Medical Holdings Corporation's preferred method for entering complex markets. This partnership model leverages local health system relationships while Select Medical Holdings Corporation provides the operational expertise. Examples of this include:

Partner Health System	Location/Market	Facility Type/Beds (Announced)
Rush University System for Health	Chicago, West Side	100-bed combined hospital (44 CIRH + 56 IR beds)
UF Health Jacksonville	Jacksonville, FL (UF Health North)	48-bed inpatient rehabilitation hospital
CoxHealth	Southwest Missouri	New inpatient rehabilitation hospital (opening Q4 2025 tentative)
SSM Health	Oklahoma City, OK	50-bed inpatient rehabilitation hospital

These joint ventures, such as the one with CoxHealth in Springfield, Missouri, are designed to consolidate existing care and bring new, updated capacity online, showing a clear preference for market entry through collaboration.

Select Medical Holdings Corporation (SEM) - Ansoff Matrix: Product Development

You're looking at how Select Medical Holdings Corporation (SEM) plans to grow by creating new services or significantly improving existing ones, which is the Product Development quadrant of the Ansoff Matrix. This isn't just about adding beds; it's about enhancing the care delivery model itself. The company is banking on these product enhancements to help achieve its full-year 2025 revenue target of between $5.3 billion and $5.5 billion. For context, Select Medical Holdings Corporation reported total revenue of $1,353.2 million for the first quarter ended March 31, 2025, representing a 2.4% increase year-over-year.

The strategy involves deep technological integration to support these new service offerings. Investments in data analytics are crucial here, as better data helps justify the revenue projections and improve clinical efficiency across the board. For instance, in the second quarter of 2025, total revenue was $1.3 billion, a nearly 5% increase year-over-year, showing momentum in the core business that these new products aim to accelerate.

Here's a breakdown of the key product development initiatives and the scale of the existing infrastructure they are targeting:

• Integrate and expand telehealth services across the existing network, which included 1,919 Outpatient Rehabilitation Clinics as of June 30, 2025, for remote monitoring.
• Develop specialized clinical programs for complex conditions like neuro-rehabilitation or pulmonary care.
• Invest in data analytics to improve patient outcomes, which helps justify the $5.3 billion to $5.5 billion revenue target for 2025.
• Launch a proprietary patient engagement app to streamline scheduling and post-discharge follow-up.
• Standardize clinical protocols across all 104 Critical Illness Recovery Hospitals as of June 30, 2025, to enhance quality consistency.

The focus on the Rehabilitation Hospital segment is clear, as its revenue grew by 16.4% for the six months ended June 30, 2025, compared to the same period in 2024. This segment is slated for significant physical product expansion, with plans to add 440 additional beds by 2027. The outpatient segment, however, showed a net reduction in clinics in Q1 2025, adding 10 new clinics but closing or consolidating 13 locations to optimize resources.

The current revenue mix shows where the existing 'products' stand, which informs where new product investment is most needed:

Segment	Revenue Contribution (Six Months Ended June 30, 2025)
Critical Illness Recovery Hospitals	46%
Rehabilitation Hospitals	23%
Outpatient Rehabilitation Clinics	24%

The push for new digital products, like the patient engagement app, is designed to improve patient flow and adherence, which directly impacts revenue per visit in the outpatient setting. For the first quarter of 2025, the outpatient rehabilitation segment's Adjusted EBITDA margin was 7.9%. Standardizing protocols across the 104 Critical Illness Recovery Hospitals is a quality product initiative, especially since that segment saw its Adjusted EBITDA margin drop to 13.6% in Q1 2025 from 17.7% the prior year. If onboarding takes 14+ days, churn risk rises.

Developing specialized clinical programs is a direct product enhancement strategy to capture higher acuity and complexity, which typically translates to higher reimbursement rates. This is vital as the company works toward its 2025 Adjusted EBITDA target of $510.0 million to $530.0 million. The investment in data analytics supports this by providing the evidence base for these specialized programs and justifying their adoption to payers.

Finance: draft 13-week cash view by Friday.

Select Medical Holdings Corporation (SEM) - Ansoff Matrix: Diversification

You're looking at how Select Medical Holdings Corporation can push beyond its core, which is smart given the current operational snapshot. For the nine months ended September 30, 2025, Select Medical Holdings Corporation generated revenue of $4,056.2 million, with the third quarter alone hitting $1,363.4 million, a 7.2% increase year-over-year. Still, diversification into new markets is a classic growth lever.

Acquire or build a home health segment to capture post-acute care in the patient's home.

This move targets the continuum of care immediately following acute or rehab hospital stays. Select Medical Holdings Corporation currently operates 1,922 outpatient rehabilitation clinics across 39 states and the District of Columbia as of September 30, 2025. Capturing the home health component means capturing patients before they transition to outpatient or even as an alternative to inpatient stays. The broader market trend supports this, with projections holding that by 2030, more than half of the American population will be over 65, driving incessant long-term demand for post-acute services.

Develop a licensed software-as-a-service (SaaS) platform for post-acute care management for non-competing hospitals.

This is a product development play into a service offering. Consider the scale: the Outpatient Rehabilitation segment brought in $325.4 million in revenue for the third quarter of 2025. A successful SaaS platform could generate high-margin, recurring revenue streams independent of patient volume fluctuations in the core segments. The company is generally focused on technological integration to enhance operational efficiency.

Enter a new, related market like primary care clinics or urgent care centers.

While Select Medical Holdings Corporation is heavily weighted in specialized care, entering primary care or urgent care represents a market development strategy that leverages existing clinical infrastructure knowledge. As of September 30, 2025, the company operates 105 critical illness recovery hospitals and 36 rehabilitation hospitals. These facilities are often referral sources, so integrating a primary care or urgent care front-end could streamline patient acquisition and management across the entire care spectrum.

Explore international expansion, perhaps starting with a pilot of the Outpatient Rehabilitation model in Canada.

Currently, Select Medical Holdings Corporation's footprint is firmly domestic, operating in 40 states and the District of Columbia as of September 30, 2025. Moving to Canada for the Outpatient Rehabilitation model would be a true market development effort. The existing outpatient segment generated $325.4 million in Q3 2025 revenue. A pilot program would test the scalability of this model outside the US regulatory and reimbursement environment.

Invest in a medical device or health technology startup focused on rehabilitation defintely.

This is a pure diversification play, moving into the technology supply side. Select Medical Holdings Corporation is already committed to innovation and strategic partnerships to enhance service delivery. Such an investment could yield financial returns and provide proprietary access to tools that improve patient outcomes in their existing 1,922 outpatient clinics or 36 rehabilitation hospitals.

Here's a quick look at the core financial performance leading into these potential moves:

Metric	Q3 2025 Amount	Nine Months Ended Sep 30, 2025 Amount	Full Year 2025 Guidance Midpoint
Total Revenue	$1,363.4 million	$4,056.2 million	$5.4 billion
Adjusted EBITDA	$111.7 million	Not explicitly stated, but Q3 is up 7.5% YoY	$520 million
Rehab Hospital Revenue	$328.6 million	Not explicitly stated	N/A
Stock Price (as of 9/30/2025)	$12.84	N/A	N/A

The current operational footprint provides the baseline for expansion:

• Critical Illness Recovery Hospitals: 105 facilities in 29 states.
• Rehabilitation Hospitals: 36 facilities in 14 states.
• Outpatient Rehabilitation Clinics: 1,922 locations in 39 states + DC.
• Planned Rehab Bed Expansion: 382 beds by H1 2027.

If onboarding takes 14+ days for a new segment, churn risk rises.

Finance: draft 13-week cash view by Friday.